Hurst M M, Volanakis J E, Stroud R M, Bennett J C
J Clin Invest. 1976 Jul;58(1):16-21. doi: 10.1172/JCI108445.
The purpose of this study was to examine the molecular parameters necessary for initiation of complement fixation by IgM proteins. To determine why some IgM molecules are capable of complement fixation while others are not, several different Waldenström IgM proteins were examined for their ability to fix total hemolytic complement in the CH(50) assay. Subsequently, the C1 fixing ability of a 56-residue fragment derived from the Cmu4 domain of each of these IgM molecules was studied with C1 fixation assay. One of the three Waldenström IgM proteins (Gr) used in the present study was found unable to consume complement in a CH(50) assay when tested at the same concentration as the two complement-consuming IgM molecules (Dau and Bus). However, when the 56-residue C(H)4 fragment from the Cmu4 domain of each IgM molecule was tested for C1-fixing ability, all three were found to bind C1. On the basis of these observations, it is proposed that a C1 binding site exists within the Cmu4 domain of both complement-fixing and noncomplement-fixing IgM molecules. Presumably, the latter molecules are unable to interact in their native state with C1 in the manner required for initiation of the classical complement pathway, possibly due to the configurational inaccessibility of the entire C1 binding site.
本研究的目的是检测IgM蛋白启动补体固定所需的分子参数。为了确定为何有些IgM分子能够固定补体而其他分子不能,研究人员检测了几种不同的华氏巨球蛋白(Waldenström)IgM蛋白在CH50试验中固定总溶血补体的能力。随后,采用C1固定试验研究了源自这些IgM分子Cμ4结构域的一个56个残基片段的C1固定能力。本研究中使用的三种华氏巨球蛋白IgM蛋白之一(Gr),在与另外两种能消耗补体的IgM分子(Dau和Bus)相同浓度下进行检测时,发现在CH50试验中无法消耗补体。然而,当检测源自每个IgM分子Cμ4结构域的56个残基C(H)4片段的C1固定能力时,发现所有三种片段均能结合C1。基于这些观察结果,有人提出在能固定补体和不能固定补体的IgM分子的Cμ4结构域内均存在一个C1结合位点。据推测,后一种分子在天然状态下无法以启动经典补体途径所需的方式与C1相互作用,这可能是由于整个C1结合位点在构象上无法接近所致。